More Than 130 Healthcare Groups Express Support for Legislation Expanding Medicare Patients Access to Pharmacist Services
News provided by
Share this article
Share this article
WASHINGTON, May 25, 2021 /PRNewswire/ Today, more than 130 healthcare groups applauded the introduction of the Pharmacy and Medically Underserved Areas Enhancement Act (S. 1362, H.R. 2759), legislation that will ensure that Medicare beneficiaries in medically underserved areas have access to pharmacists primary care services.
In a letter sent to the bill s original sponsors Sen. Chuck Grassley (R-IA), Sen. Bob Casey (D-PA), Sen. Sherrod Brown (D-OH), Rep. G.K. Butterfield (D-NC), and Rep. David McKinley (R-WV) the healthcare groups, including rural health advocates, consumer groups, and pharmacy organizations, call for the removal of restrictions on seniors access to care.
Grand Rapids Business Journal Keystone Pharmacy’s Thomas A. Magnifico has been inducted as a fellow with the American College of Apothecaries. Magnifico has more than 30 years experience as a pharmacist, working in a breadth of settings from health systems to retail and with a strong background in administration and management. His current focus is as a veterinary compounding specialist.The ACA was founded in 1940 to educate, mentor and train pharmacists. ACCOUNTING
Michael Gruennert, senior audit accountant,
Jessica Giddings, staff accountant, and
Scott Stancill, senior accountant.
Scott Cathey, engineering technician in its Holland office;
Duane Schweigert, inspector in its Grand Rapids office; and
Managing Editor
The first vaccine to prevent COVID-19 has been cleared for use in the United States. The Food and Drug Administration on Saturday granted emergency use authorization to Pfizer and BioNTech’s COVID-19 vaccine for use in individuals 16 years old and older. The first shipments began leaving facilities on Sunday.
The FDA’s decision was based on data from its Phase 3 clinical study, whose results were published last week in the New England Journal of Medicine and which saw a 95% vaccine efficacy rate. The two companies continue to gather additional data and prepare a biologics license application for full approval from the FDA in 2021.
Share this article
Share this article
WASHINGTON, Dec. 11, 2020 /PRNewswire/ The leaders of 18 pharmacy organizations today issued the following statement following the Food and Drug Administration s approval of the first Emergency use Authorization for the COVID-19 vaccine. We heartily welcome the decision by the US Food and Drug Administration (FDA) to authorize the emergency use of the first COVID-19 vaccine, following the recommendation of the Vaccines and Related Biological Products Advisory Committee (VRBPAC). This is a historic moment in the nation s effort to end the pandemic. The pharmacy profession is ready to do its part as qualified, active participants in administering these vaccines in accordance with guidance issued by the FDA, CDC, HHS and state and local health departments, as well as increasing access for the American public to these important disease prevention tools.